A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)
A Phase 2, Open-Label Study to explore the efficacy, safety, and tolerability of psilocybin-assisted therapy in women with sexual assault-related Posttraumatic Stress Disorder (PTSD).
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Sunstone Medical
- Principal investigator
- Manish Agrawal, MD, MSC
- Start date
- 2026-05-23
- End date
- 2028-05-01
- Registry ID
- NCT06902974
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.